enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Familial partial lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Familial_partial_lipodystrophy

    Familial partial lipodystrophy, also known as Köbberling–Dunnigan syndrome, [2] is a rare genetic metabolic condition characterized by the loss of subcutaneous fat. [ 3 ] : 495 FPL also refers to a rare metabolic condition in which there is a loss of subcutaneous fat in the arms, legs and lower torso.

  3. Dunnigan familial partial lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Dunnigan_familial_partial...

    Familial Partial Lipodystrophy, Dunnigan Type Autosomal dominant is the manner of inheritance of this condition Dunnigan-type familial partial lipodystrophy , also known as FPLD Type II and abbreviated as ( FPLD2 ), is a rare monogenic form of insulin resistance characterized by loss of subcutaneous fat from the extremities , trunk , and ...

  4. Lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Lipodystrophy

    Lipodystrophy can be divided into the following types: [5]: 495–7 Congenital lipodystrophy syndromes Congenital generalized lipodystrophy (Berardinelli-Seip syndrome) Familial partial lipodystrophy; Marfanoid–progeroid–lipodystrophy syndrome; Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome [6]

  5. Barraquer–Simons syndrome - Wikipedia

    en.wikipedia.org/wiki/Barraquer–Simons_syndrome

    Barraquer–Simons syndrome is a rare form of lipodystrophy, which usually first affects the head, and then spreads to the thorax. [2] [3] It is named for Luis Barraquer Roviralta (1855–1928), a Spanish physician, and Arthur Simons (1879–1942), a German physician.

  6. Metreleptin - Wikipedia

    en.wikipedia.org/wiki/Metreleptin

    Metreleptin, sold under the brand name Myalept among others, is a synthetic analog of the hormone leptin used to treat various forms of dyslipidemia.It has been approved in Japan for metabolic disorders including lipodystrophy and in the United States as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired ...

  7. The Terrible—and Amazing—Side Effects of Weight-Loss Drugs

    www.aol.com/terrible-amazing-side-effects-weight...

    Muscle Loss. IF YOU DROP 15 to 25 percent of your body weight, 15 to 60 percent of that could be lean mass (muscle, bone, anything but fat). Strength training helps counter that. In one study of ...

  8. Acquired generalized lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Acquired_generalized...

    Acquired generalized lipodystrophy (AGL), also known as Lawrence syndrome [1] and Lawrence–Seip syndrome, [1] is a rare skin condition that appears during childhood or adolescence, characterized by fat loss affecting large areas of the body, particularly the face, arms, and legs.

  9. List of syndromes - Wikipedia

    en.wikipedia.org/wiki/List_of_syndromes

    Familial cold autoinflammatory syndrome; Familial Mediterranean fever; Familial partial lipodystrophy; Familial Adenomatous Polyposis; Fanconi syndrome; Favre–Racouchot syndrome; Febrile infection-related epilepsy syndrome; Febrile neutrophilic dermatosis; Fechtner syndrome; Feingold syndrome; Feline hyperesthesia syndrome; Felty's syndrome ...